ResearchMar 19, 2025Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60
ResearchMar 19, 2025Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions
ResearchMar 19, 2025Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia
ResearchNov 21, 2024Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes
Press ReleasesNov 13, 2024Helix Debuts Novel Precision Effectiveness Model That Predicts 12-Month Weight Loss Response of Semaglutide in Diverse Populations
ResearchNov 4, 2024A novel method for predicting Lp(a) levels from routine outpatient genomic testing identifies those at risk of cardiovascular disease across a diverse cohort
Press ReleasesOct 30, 2024Helix to Showcase the Impact of Clinico-Genomic Research on Clinical Care and Drug Discovery at ASHG Annual Meeting
ResearchAug 6, 2024Reduced Likelihood of Hospitalization With the JN.1 or HV.1 Severe Acute Respiratory Syndrome Coronavirus 2 Variants Compared With the EG.5 Variant